Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0002007191-25-000007
Filing Date
2025-01-13
Accepted
2025-01-13 16:03:30
Documents
37
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS f6-KJPM.htm 6-K 11015
2 EX-99.1 q4bizupdate.htm EX-99.1 31030
3 EX-99.2 prez1.htm EX-99.2 32132
4 jpprez11.jpg GRAPHIC 157659
5 prez12.jpg GRAPHIC 467736
6 prez13.jpg GRAPHIC 254142
7 prez14.jpg GRAPHIC 235157
8 prez15.jpg GRAPHIC 261788
9 prez16.jpg GRAPHIC 155988
10 prez17.jpg GRAPHIC 227895
11 prez18.jpg GRAPHIC 203450
12 prez19.jpg GRAPHIC 162547
13 prez110.jpg GRAPHIC 229607
14 prez111.jpg GRAPHIC 210873
15 prez112.jpg GRAPHIC 159310
16 prez113.jpg GRAPHIC 259050
17 prez114.jpg GRAPHIC 259658
18 prez115.jpg GRAPHIC 259518
19 prez116.jpg GRAPHIC 268837
20 prez117.jpg GRAPHIC 223989
21 prez118.jpg GRAPHIC 161089
22 prez119.jpg GRAPHIC 234654
23 prez120.jpg GRAPHIC 227087
24 prez121.jpg GRAPHIC 243491
25 prez122.jpg GRAPHIC 240038
26 prez123.jpg GRAPHIC 265132
27 prez124.jpg GRAPHIC 305113
28 prez125.jpg GRAPHIC 155005
29 prez126.jpg GRAPHIC 206439
30 prez127.jpg GRAPHIC 111477
31 prez128.jpg GRAPHIC 203257
32 prez129.jpg GRAPHIC 174533
33 prez130.jpg GRAPHIC 130803
34 prez131.jpg GRAPHIC 187932
35 prez132.jpg GRAPHIC 221096
36 prez133.jpg GRAPHIC 150195
37 image1-1.gif GRAPHIC 35096
  Complete submission text file 0002007191-25-000007.txt   10061071
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42128 | Film No.: 25526358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)